Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEB-TACE vs cTACE for Downstaging HCC Beyond UCSF Criteria
NCT04738188Recruiting
- Sponsor
- Beijing Tsinghua Changgung Hospital
- Start
- Mar 2020
- Primary completion
- Nov 2022
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Beijing Tsinghua Changgung Hospital. Primary endpoint: Downstaging success rate at 6 months. Started Mar 2020; status: recruiting.
Beyond the preview
Go deeper on NCT04738188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04738188.